Norris Medicines

{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.00",
    "chg": -0.75,
    "chgp": "-5.08%",
    "dir": -1,
    "prev_price": "14.75",
    "mcapval": "15.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE744C01029",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "373 ",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines Ltd Falls to 52-Week Low of Rs 12 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3909902",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NorrisMedicines_priceRelatedfactors_3909902.png",
        "date": "2026-03-24 09:50:06",
        "description": "For the fourth consecutive session, Norris Medicines Ltd has closed lower, culminating in a fresh 52-week low of Rs 12 on 24 Mar 2026. This marks a 14.09% decline over the past four days, underscoring sustained selling pressure despite some pockets of strength in the broader market."
      },
      {
        "title": "Norris Medicines Ltd Falls to 52-Week Low of Rs 12.45 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-falls-to-52-week-low-of-rs1245-3907569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NorrisMedicines_priceRelatedfactors_3907569.png",
        "date": "2026-03-23 11:45:54",
        "description": ""
      },
      {
        "title": "Norris Medicines Ltd Reports Strong Quarterly Growth Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-reports-strong-quarterly-growth-amid-market-challenges-3843086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NorrisMedicines_fintrenddot_3843086.png",
        "date": "2026-02-17 08:00:10",
        "description": "Norris Medicines Ltd has demonstrated a marked turnaround in its financial trajectory during the December 2025 quarter, posting robust revenue growth and record profitability metrics despite a challenging market environment. The company’s financial trend has shifted from flat to positive, signalling renewed operational momentum within the Trading & Distributors sector."
      },
      {
        "title": "Are Norris Medicines Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-norris-medicines-ltd-latest-results-good-or-bad-3840599",
        "imagepath": "",
        "date": "2026-02-14 19:58:26",
        "description": "Norris Medicines Ltd's latest financial results for Q2 FY26 present a complex picture. On one hand, the company reported net sales of ₹2.00 crores, reflecting a sequential growth of 36.99% from ₹1.46 crores in Q1 FY26 and a year-on-year increase of 57.48% from ₹1.27 crores in Q2 FY25. This topline growth suggests some market traction; however, it is overshadowed by significant operational challenges.\n\nThe net loss for the quarter was ₹0.72 crores, which marks a substantial deterioration compared to the previous quarter's loss of ₹0.31 crores. The operating margin fell to -24.50%, a sharp decline from -6.85% in Q1 FY26, indicating that the company's ability to manage costs relative to its sales has worsened considerably. This operational performance is concerning, as it highlights a widening gap between revenue growth and profitability, with the gross profit margin reported at a negative 30.00%.\n\nFurthermore..."
      },
      {
        "title": "When is the next results date for Norris Medicines Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-norris-medicines-ltd-3836095",
        "imagepath": "",
        "date": "2026-02-12 23:16:40",
        "description": "The next results date for Norris Medicines Ltd is scheduled for 14 February 2026...."
      }
    ],
    "total": 254,
    "sid": "210607",
    "stock_news_url": "https://www.marketsmojo.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "20-Apr-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting Held On 14Th February 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "14-Feb-2026",
      "details": "As per attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Norris Medicines Ltd Falls to 52-Week Low of Rs 12 as Sell-Off Deepens

2026-03-24 09:50:06

For the fourth consecutive session, Norris Medicines Ltd has closed lower, culminating in a fresh 52-week low of Rs 12 on 24 Mar 2026. This marks a 14.09% decline over the past four days, underscoring sustained selling pressure despite some pockets of strength in the broader market.

Read full news article

Norris Medicines Ltd Falls to 52-Week Low of Rs 12.45 as Sell-Off Deepens

2026-03-23 11:45:54

Read full news article

Norris Medicines Ltd Reports Strong Quarterly Growth Amid Market Challenges

2026-02-17 08:00:10

Norris Medicines Ltd has demonstrated a marked turnaround in its financial trajectory during the December 2025 quarter, posting robust revenue growth and record profitability metrics despite a challenging market environment. The company’s financial trend has shifted from flat to positive, signalling renewed operational momentum within the Trading & Distributors sector.

Read full news article

Are Norris Medicines Ltd latest results good or bad?

2026-02-14 19:58:26

Norris Medicines Ltd's latest financial results for Q2 FY26 present a complex picture. On one hand, the company reported net sales of ₹2.00 crores, reflecting a sequential growth of 36.99% from ₹1.46 crores in Q1 FY26 and a year-on-year increase of 57.48% from ₹1.27 crores in Q2 FY25. This topline growth suggests some market traction; however, it is overshadowed by significant operational challenges. The net loss for the quarter was ₹0.72 crores, which marks a substantial deterioration compared to the previous quarter's loss of ₹0.31 crores. The operating margin fell to -24.50%, a sharp decline from -6.85% in Q1 FY26, indicating that the company's ability to manage costs relative to its sales has worsened considerably. This operational performance is concerning, as it highlights a widening gap between revenue growth and profitability, with the gross profit margin reported at a negative 30.00%. Furthermore...

Read full news article

When is the next results date for Norris Medicines Ltd?

2026-02-12 23:16:40

The next results date for Norris Medicines Ltd is scheduled for 14 February 2026....

Read full news article

View All News